Genome scan of M. tuberculosis infection and disease in Ugandans.

by Catherine M Stein, Sarah Zalwango, LaShaunda L Malone, Sungho Won, Harriet Mayanja-Kizza, Roy D Mugerwa, Dmitry V Leontiev, Cheryl L Thompson, Kevin C Cartier, Robert C Elston, Sudha K Iyengar, W Henry Boom, Christopher C Whalen
Published 2008-01-01

Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data.

by Allison R Baker, Feiyou Qiu, April Kaur Randhawa, David J Horne, Mark D Adams, Muki Shey, Jill Barnholtz-Sloan, Harriet Mayanja-Kizza, Gilla Kaplan, Willem A Hanekom, W Henry Boom, Thomas R Hawn, Catherine M Stein, Tuberculosis Research Unit and South African Tuberculosis Vaccine Initiative Team
Published 2012-01-01

Enrichment of HIV-1 subtype AD recombinants in a Ugandan cohort of severely septic patients.

by Najah I Doka, Shevin T Jacob, Patrick Banura, Christopher C Moore, David Meya, Harriet Mayanja-Kizza, Steven J Reynolds, W Michael Scheld, Wen Yuan
Published 2012-01-01

Dental Caries Pattern and Treatment Needs among Ugandan Adolescent Students: A Cross-Sectional Study

by Barbara Ndagire, Catherine L. Mwesigwa, Juliet M. Ntuulo, Harriet Mayanja-Kizza, Damalie Nakanjako, Charles M. Rwenyonyi
Published 2020-01-01

Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study

by Adriane Kamulegeya, Damalie Nakanjako, Jackson Orem, Harriet Mayanja-Kizza
Published 2021-03-01

Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.

by Shevin T Jacob, Christopher C Moore, Patrick Banura, Relana Pinkerton, David Meya, Pius Opendi, Steven J Reynolds, Nathan Kenya-Mugisha, Harriet Mayanja-Kizza, W Michael Scheld, Promoting Resource-Limited Interventions for Sepsis Management in Uganda (PRISM-U) Study Group
Published 2009-11-01

Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

by C Scott Mahan, Maria Walusimbi, Denise F Johnson, Christina Lancioni, Edwin Charlebois, Joyce Baseke, Keith A Chervenak, Roy D Mugerwa, Diane V Havlir, Harriet Mayanja-Kizza, Christopher C Whalen, W Henry Boom, Uganda-Case Western Research Collaboration
Published 2010-02-01

Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial

by Pauline Byakika-Kibwika, Jane Achan, Mohammed Lamorde, Carine Karera-Gonahasa, Agnes N. Kiragga, Harriet Mayanja-Kizza, Noah Kiwanuka, Sam Nsobya, Ambrose O. Talisuna, Concepta Merry
Published 2017-12-01

Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivati...

by Shevin T Jacob, Patricia B Pavlinac, Lydia Nakiyingi, Patrick Banura, Jared M Baeten, Karen Morgan, Amalia Magaret, Yuka Manabe, Steven J Reynolds, W Conrad Liles, Anna Wald, Moses L Joloba, Harriet Mayanja-Kizza, W Michael Scheld
Published 2013-01-01

Interaction between host genes and Mycobacterium tuberculosis lineage can affect tuberculosis severity: Evidence for coevolution?

by Michael L McHenry, Jacquelaine Bartlett, Robert P Igo, Eddie M Wampande, Penelope Benchek, Harriet Mayanja-Kizza, Kyle Fluegge, Noemi B Hall, Sebastien Gagneux, Sarah A Tishkoff, Christian Wejse, Giorgio Sirugo, W Henry Boom, Moses Joloba, Scott M Williams, Catherine M Stein
Published 2020-04-01

The effect of a bidirectional exchange on faculty and institutional development in a global health collaboration.

by Benjamin E Bodnar, Cassidy W Claassen, Julie Solomon, Harriet Mayanja-Kizza, Asghar Rastegar
Published 2015-01-01

Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.

by Chetan Seshadri, Nafiseh Sedaghat, Monica Campo, Glenna Peterson, Richard D Wells, Gregory S Olson, David R Sherman, Catherine M Stein, Harriet Mayanja-Kizza, Ali Shojaie, W Henry Boom, Thomas R Hawn, Tuberculosis Research Unit (TBRU)
Published 2017-01-01

Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.

by Melissa R Nyendak, Byung Park, Megan D Null, Joy Baseke, Gwendolyn Swarbrick, Harriet Mayanja-Kizza, Mary Nsereko, Denise F Johnson, Phineas Gitta, Alphonse Okwera, Stefan Goldberg, Lorna Bozeman, John L Johnson, W Henry Boom, Deborah A Lewinsohn, David M Lewinsohn, Tuberculosis Research Unit and the Tuberculosis Trials Consortium
Published 2013-01-01

Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

by Denise F Johnson, LaShaunda L Malone, Sarah Zalwango, Joy Mukisa Oketcho, Keith A Chervenak, Bonnie Thiel, Harriet Mayanja-Kizza, Catherine M Stein, W Henry Boom, Christina L Lancioni, Tuberculosis Research Unit
Published 2014-01-01

Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity

by Isaac Ssewanyana, Isaac Ssewanyana, John Rek, Isabel Rodriguez, Lindsey Wu, Emmanuel Arinaitwe, Emmanuel Arinaitwe, Joaniter I. Nankabirwa, Joaniter I. Nankabirwa, James G. Beeson, James G. Beeson, James G. Beeson, Harriet Mayanja-Kizza, Philip J. Rosenthal, Grant Dorsey, Moses R. Kamya, Moses R. Kamya, Chris Drakeley, Bryan Greenhouse, Bryan Greenhouse, Kevin K. A. Tetteh
Published 2021-01-01